Ion Robotic Bronchoscopy
A platform for minimally invasive peripheral lung biopsy advancing robotics in thoracic oncology
In lung cancer, time to intervention is critical. Ion enables clinical confidence to get early answers and accelerates program impact. Ion delivers meaningful innovation so clinicians can continue to advance care for their lung cancer patients.
We built Ion on the belief that collecting lung tissue samples for biopsy could be safe and simple, even when lung nodules are small and located in the periphery. Ion’s ultrathin, ultramaneuverable catheter allows clinicians to reach small lesions in all 18 segments of the lung with more reach, precision, and stability.1
Many patients currently require multiple biopsies prior to lung cancer diagnosis, which can add months to a patient’s journey to care.2 One goal in designing Ion was to help shorten the patient journey by making it possible to reach and biopsy difficult-to-reach nodules in the peripheral lung, where more than 70% of cancerous lung nodules may be located.3 Ion wasn’t designed to answer every need; but to support finding answers faster along a less invasive path to diagnosis.
Ongoing commitment to collaborative innovation aims to provide lung cancer centers with a platform for the future. Developed in partnership with the care community, Ion delivers meaningful innovation designed to continually advance lung care.
By submitting my information, I am agreeing to receive information regarding Intuitive products and services and related topics. More information may be found in our privacy policy.
Thank you for your information. An Intuitive representative will be in touch.
Design and implementation have been rigorously evaluated and awarded third-party certifications for privacy and security compliance with globally recognized HITRUST and NIST Cybersecurity & Privacy Frameworks.
Important safety information
Risks associated with bronchoscopy through an endotracheal tube and under general anesthesia are infrequent and typically minor, and may include but are not limited to: sore throat, hoarseness, respiratory complications including dyspnea or hypoxemia, airway injury, bronchospasm, laryngospasm, fever, hemoptysis, chest or lung infection including pneumonia, lung abscess or an adverse reaction to anesthesia. Although rare, the following complications may also occur: bleeding, pneumothorax (collapsed lung), cardiac related complications, respiratory failure, air embolism, or death. As with other medical procedures, there may be additional risks associated with the use of general anesthesia and/or endotracheal intubation which are not listed above; you should consult a health care professional regarding these and other potential risks.
Procedures using the Ion Endoluminal System may be associated with longer procedure and/or longer anesthesia time.
Individuals’ outcomes may depend on a number of factors—including but not limited to—patient characteristics, disease characteristics, and/or physician experience.
Ion endoluminal system
The Ion endoluminal system (Model IF1000) assists the user in navigating a catheter and endoscopic tools in the pulmonary tract using endoscopic visualization of the tracheobronchial tree for diagnostic and therapeutic procedures. The Ion endoluminal system enables fiducial marker placement. It does not make a diagnosis and is not for pediatric use.
Information provided by the Ion endoluminal system or its components should be considered guidance only and not replace clinical decisions made by a trained physician.
The Flexision Biopsy Needle is used with the Ion Endoluminal System to biopsy tissue from a target area in the lung.
The PlanPoint Software uses patient CT scans to create a 3D plan of the lung and navigation pathways for use with the Ion Endoluminal System.
